(MENAFN- EIN Presswire) Leading companies such as Inotrem, Adrenomed, Shionogi, Asahi Kasei Pharma Corp., are driving advancements in Sepsis treatments to enhance patient care. LAS VEGAS , NV ...

Emerging Therapies in the Sepsis are VBI-S, Nangibotide, Giapreza, Vasostrict, Onoact Injection (Landiolol hydrochloride), Allocetra, Adrecizumab, Fetroja/Fetcroja (Cefiderocol), Recomodulin (ART-123) ...

NEW FLUORINE-CONTAINING DRUG FROM CHINA: Prusogliptin （ Trade name：Shanzeping, 善泽平）, A novel oral DPP-4 inhibitor ， Developed by by CSPC Pharmaceutical Group Co., Ltd., CHINA ...